UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
9901
DELISTED
ProShares Supply Chain Logistics ETF
SUPL
| $183 | ﹤0.01% |
+4
| New | +$182 |
2026 Q2
0 quarters
|
|
|
OSRH
9902
DELISTED
OSR Health
OSRH
| $183 | ﹤0.01% |
580
-3,896
| -87% | -$1.95K |
2025 Q4
2 quarters
|
|
9903
MFS Blended Research Small-Mid Cap ETF
BRSM
| $182 | ﹤0.01% |
+7
| New | +$176 |
2026 Q2
0 quarters
|
|
9904
iHuman
IH
$59.3M
| $181 | ﹤0.01% |
129
+30
| +30% | +$48 |
2024 Q3
7 quarters
|
|
9905
Decoy Therapeutics
DCOY
$727K
| $180 | ﹤0.01% |
25
-521
| -95% | -$3.2K |
2023 Q3
11 quarters
|
|
9906
Australian Oilseeds Holdings Ltd Warrant
COOTW
$171K
| $180 | ﹤0.01% |
+7,516
| New | +$165 |
2026 Q2
0 quarters
|
|
9907
The Generation Essentials Group Warrants
TGE.WS
| $176 | ﹤0.01% |
1,352
| – | – |
2026 Q1
1 quarter
|
|
|
PCR
9908
DELISTED
Simplify VettaFi Private Credit Strategy ETF
PCR
| $176 | ﹤0.01% |
+9
| New | +$181 |
2026 Q2
0 quarters
|
|
9909
Sound Enhanced Fixed Income ETF
FXED
$37M
| $175 | ﹤0.01% |
10
-318
| -97% | -$5.59K |
2025 Q4
2 quarters
|
|
9910
Grove Collaborative
GROV
$47M
| $175 | ﹤0.01% |
140
-2
| -1% | -$2 |
2023 Q1
13 quarters
|
|
9911
Harbor Emerging Markets Select ETF
EMES
$10.2M
| $173 | ﹤0.01% |
6
| – | – |
2026 Q1
1 quarter
|
|
9912
Calisa Acquisition Corp
ALIS
$69.7M
| $173 | ﹤0.01% |
+17
| New | +$172 |
2026 Q2
0 quarters
|
|
9913
Scully Royalty
SRL
$61.4M
| $172 | ﹤0.01% |
28
+26
| +1,300% | +$181 |
2023 Q4
10 quarters
|
|
|
COLAR
9914
DELISTED
Columbus Acquisition Corp Rights
COLAR
| $171 | ﹤0.01% |
+311
| New | +$145 |
2026 Q2
0 quarters
|
|
9915
Research Alliance Corp III
RACC
$92.4M
| $171 | ﹤0.01% |
+16
| New | +$167 |
2026 Q2
0 quarters
|
|
9916
Netcapital Inc Warrants
NCPLW
| $170 | ﹤0.01% |
8,500
+8,200
| +2,733% | +$222 |
2025 Q3
3 quarters
|
|
9917
Churchill Capital Corp XII Warrants
CXIIW
$4.26M
| $170 | ﹤0.01% |
+100
| New | +$134 |
2026 Q2
0 quarters
|
|
9918
1RT Acquisition Corp Warrant
ONCHW
$1.38M
| $166 | ﹤0.01% |
327
| – | – |
2026 Q1
1 quarter
|
|
9919
Blueport Acquisition Ltd Units
BPACU
| $165 | ﹤0.01% |
+16
| New | +$166 |
2026 Q2
0 quarters
|
|
9920
Arrive AI Inc
ARAI
$5.98M
| $164 | ﹤0.01% |
382
-4,456
| -92% | -$2.99K |
2025 Q2
4 quarters
|
|
9921
CNFinance Holdings
CNF
$33.7M
| $161 | ﹤0.01% |
58
+39
| +205% | +$120 |
2020 Q4
22 quarters
|
|
9922
BuzzFeed Inc Warrant
BZFDW
$216K
| $160 | ﹤0.01% |
+6,403
| New | +$170 |
2026 Q2
0 quarters
|
|
9923
Trailblazer Acquisition Corp Warrant
BLZRW
$2.38M
| $160 | ﹤0.01% |
400
| – | – |
2025 Q4
2 quarters
|
|
9924
Anghami
ANGH
$30.5M
| $156 | ﹤0.01% |
48
-610
| -93% | -$2.39K |
2023 Q3
11 quarters
|
|
9925
KraneShares 90% KWEB Defined Outcome January 2026 ETF
KBUF
$5.69M
| $156 | ﹤0.01% |
+6
| New | +$165 |
2026 Q2
0 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.